期刊文献+

CHFR在人肝癌HepG2细胞中的表达及对其凋亡作用的影响 被引量:1

The expression of CHFR in hepatoma carcinoma cell HepG2 and its effect on cellular apoptosis
原文传递
导出
摘要 目的研究细胞有丝分裂前期检查点(checkpoint with forkhead associated and ring finger,CHFR)在人肝癌细胞株HepG2中的表达,以及CHFR基因甲基化对HepG2细胞凋亡作用的影响。方法采用去甲基化剂5-氮-2-脱氧胞苷(5-Aza-2-deoxycytidine,Aza)处理人肝癌细胞株HepG2,半定量RT-PCR和Western-Blot检测CHFR在HepG2细胞中的表达水平,FCM分析HepG2细胞的凋亡情况。结果 CHFR在HepG2细胞中表达缺失;经Aza去甲基化处理后,CHFR在HepG2细胞中逐渐恢复表达,肿瘤细胞凋亡率逐渐增高,存在剂量-反应关系;且CHFR表达水平与HepG2细胞凋亡率呈正相关。结论在本试验条件下,CHFR在HepG2细胞中表达缺失,去甲基化后表达恢复;CHFR的高表达可以促进肝癌细胞凋亡。 Objective To study the expression of CHFR (checkpoint with forkhead associated and ring finger) in human hepatoma carcinoma cell line HepG2 and the effect of CHFR DNA methylation on the HepG2 cells apoptosis. Methods Human hepatoma carcinoma cell line HepG2 was treated by methylation inhibitor 5-Aza-2-deoxycytidine ( Aza). The expression level of CHFR in HepG2 cells was evaluated by semi-quantitative RT-PCR and Western Blot. The apoptosis of HepG2 cells was analyzed by flow cytometry. Results CHFR was not expressed in HepG2 cells. CHFR was recovered to express after the treatment of Aza. The apoptosis ratio of HepG2 cells increased. They showed dose-effect relationship. The expression level of CHFR was positively correlated with the apoptosis ratio of HepG2 cells. Conclusion In this experimental condition,CHFR was loss of expression in HepG2 cells and recovered by the methylation inhibition. CHFR hyperexpression may promote the apoptosis of hepatoma carcinoma cells.
出处 《毒理学杂志》 CAS CSCD 北大核心 2010年第3期199-202,共4页 Journal of Toxicology
关键词 CHFR HEPG2细胞 5-氮-2-脱氧胞苷 DNA甲基化 细胞凋亡 CHFR HepG2 cells 5-Aza-2-deoxycytidine DNA methylation Apoptosis
  • 相关文献

参考文献11

  • 1Scolnick DM, Halazonetis TD. Chfr defines a mitotic stress checkpoint that delays entry into metaphase [ J ]. Nature, 2000, 406(6794) :430-435. 被引量:1
  • 2Stavridi ES, Huyen Y, Loreto IR, et al. Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate [ J]. Structure, 2002, 10 (7) :891-899. 被引量:1
  • 3Mizuno K, Osada H, Konishi H, et al. Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers[J]. Oncogene, 2002, 21 (15) :2328- 2333. 被引量:1
  • 4Shibata Y, Haruki N, Kuwabara Y, et al. Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer [ J ]. Carcinogenesis, 2002, 23 (10) : 1695-1699. 被引量:1
  • 5Bertholon J, Wang Q, Falette N, et al. Chfr inactivation is not associated to chromosomal instability in colon cancers[J]. Oncogene, 2003, 22 (55) :8956-8960. 被引量:1
  • 6Toyota M, Sasaki Y, Satoh A, et al. Epigenetic inactivation of CHFR in human tumors[ J]. Proc Natl Acad Sci USA, 2003, 100(13) :7818-7823. 被引量:1
  • 7Costell JF, Fruhwald MC, Smiraglia DJ, et al. Aberrant CpG-island methylation has non-random and turnout-typespecific patterns[J]. Nat Genet, 2000, 24(2):132-138. 被引量:1
  • 8Corn PG, Summers MK, Fogt F, et al. Frequent hypermethylation of the 5'CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer[ J]. Carcinogenesis, 2003, 24( 1 ) :47-51. 被引量:1
  • 9Bender CM, Zingg JM, Jones PA. DNA methylation as a target for drug design[J]. Pharm Res, 1998, 15(2) :175-187. 被引量:1
  • 10Yuan Y, Mendez R, Sahin A, et al . Hypermethylation leads to silencing of the SYK gene in human breast cancer [J]. Cancer Res, 2001, 61(14):5558-5561. 被引量:1

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部